Presentations
NanOlogy Presentations
-
SITC 2023 Poster: Local Administration of Large Surface Area Microparticle Docetaxel is Associated with Anti-tumor Immunomodulation Across Multiple Tumor Types
October 12, 2023 by NanOlogy
-
AACR Pancreatic Cancer 2023 Poster: EUS-guided Local Administration of Large Surface Area Microparticle Paclitaxel with Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cncer: A Single Center Experience
October 5, 2023 by NanOlogy
-
AACR Pancreatic Cancer 2023 Poster: Enhancing the Immune Response in Locally Advanced Pancreatic Cancer (LAPC) with Intratumoral Endoscopic Ultrasound-guided Fine Needle Injection of Large Surface Area Microparticle Paclitaxel (LSAM-PTX)
October 5, 2023 by NanOlogy
-
ASCO 2023 Abstract: Safety of locally administered large surface area microparticle paclitaxel and docetaxel in combination with standard of care cancer therapies
June 8, 2023 by NanOlogy
-
DDW 2023 Poster: Intracystic Injection of Large Surface Area Microparticle Paclitael for Chemoablation of Intraductal Papillary Mucinous Neoplasms: Insights from an Expanded Access Protocol
May 25, 2023 by NanOlogy
-
NanOlogy General Presentation (January 2023)
January 6, 2023 by NanOlogy
-
DDW 2022 Poster: The Efficacy of Intracystic Injection of Large Surface Area Microparticle Paclitaxel (NanoPac®) in the Management of Intraductal Papillary Mucinous Neoplasms: Results from an Expanded Access Protocol
August 6, 2022 by NanOlogy
-
ACG 2021 Presentation: Improved Resection Rates in Locally Advanced Pancreatic Cancer (LAPC) Following EUS-FNI of Large Surface Area Microparticle Paclitaxel (LSAM Pac)
November 3, 2021 by NanOlogy
-
DDW 2021 Poster: Tandem EUS-Guided Fine Needle Injection of Intracystic Submicron Particle Paclitaxel (Nanopac®) as a Treatment for Branch-Duct IPMN: Safety, Pharmacokinetic, and Preliminary Efficiency
June 2, 2021 by NanOlogy
-
SABCS 2020 Poster: Phase 1/2 Clinical Trial of A Topical Submicron Particle Paclitaxel (SOR007) for the Treatment of Cutaneous Metastases
December 17, 2020 by NanOlogy
-
ASCO 2020 Abstract: Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancer undergoing cytoreductive surgery
July 2, 2020 by NanOlogy
-
Digestive Disease Week 2020: Intracystic Injection of Submicron Particle Paclitaxel (SPP) for the Treatment of Mucinous Pancreatic Cystic Lesions Resulted in Reduction in Cyst Volume, an Interim Report (Mohamed O. Othman)
May 13, 2020 by NanOlogy
-
Digestive Disease Week 2020: EUS-guided Injection of Intratumoral Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Adenocarcinoma (LAPC) – Phase 2 Study (Neil Sharma, MD)
May 13, 2020 by NanOlogy
-
Video Highlights: NanoPac Injection for Pancreatic Cancer | Neil R. Sharma, MD, Parkview Cancer Institute (3-minute version)
November 10, 2019 by NanOlogy
-
Video: NanoPac Injection for Pancreatic Cancer | Neil R. Sharma, MD, Parkview Cancer Institute (7-minute version)
November 7, 2019 by NanOlogy
-
ACG 2019 Plenary Presentation: A Novel EUS-guided Intratumoral Delivery of Submicron Particle Paclitaxel for the Treatment of Locally Advanced Pancreatic Cancer.
October 31, 2019 by NanOlogy
-
ACG 2019 Poster: NanoPac-2017-01 Mid-Study Report: Safety, Tolerability and Preliminary Efficacy of Intracyctic Submicron Particle Paclitaxel (SPP) for the Treatment of Pancreatic Mucinous Cysts
October 31, 2019 by NanOlogy
-
ATS 2019 Poster: Enhanced Tumor Regression and Immune Cell Infiltration by Inhaled Submicron Particle Paclitaxel
May 21, 2019 by NanOlogy
-
BIOCEO19 Video: Reshaping Tumor Microenvironments via Immunotherapies. Panel including Gere diZerega, MD, Chief Medical Officer of NanOlogy
February 24, 2019 by NanOlogy
-
ASCO-GU19 Poster: Evaluation of Submicron Particle Docetaxel Directly Injected into Uro-Oncologic Xenografts
February 19, 2019 by NanOlogy
